Contraceptive-Induced Weight Gain—Myth and Reality Review
Life · 27.03.2026 · 16 (4) · 553
DOI: 10.3390/life16040553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 27.03.2026. Verfasst von Tudor Butureanu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The perception that hormonal contraception causes weight gain is a general belief that frequently hinders the initiation and continuation of effective family planning. This narrative review analyses data from Cochrane systematic reviews and recent pharmacogenomic studies to separate patient perception from metabolic reality. Analysis of high-quality data, including Cochrane systematic reviews, indicates that the association between Combined Hormonal Contraceptives (CHCs)—including oral pills, the transdermal patch, and the vaginal ring—and weight gain is not supported by consistent high-quality evidence. Placebo-controlled trials demonstrate that these methods are weight-neutral on average. Perceived weight increases in CHC users are likely mediated in part by fluid retention linked to the estrogenic stimulation of the Renin–Angiotensin–Aldosterone System (RAAS), rather than adipose tissue accumulation. Conversely, Depot Medroxyprogesterone Acetate (DMPA) represents a verified clinical risk for weight gain, showing a demonstrated clinical association with significant fat mass accumulation. Hypothesized biological mechanisms for this increase include hypothalamic appetite stimulation and glucocorticoid-like activity. The etonogestrel implant occupies a complex middle ground. While population-level data suggests weight neutrality, recent exploratory pharmacogenomic research has identified a specific variant in the Estrogen Receptor 1 (ESR1) gene. For the minority of women carrying this variant, the implant may trigger clinically significant weight gain, suggesting a biological basis for their subjective experience despite statistical evidence. Ultimately, the persistence of the weight gain concern is fueled by the nocebo effect and the misattribution of natural age-related weight trajectories to contraceptive use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Department of Mother and Child, "Elena Doamna" University Hospital of Obstetrics and Gynecology, 700398 Iasi, Romania.
- Pathology Department, "Elena Doamna" University Hospital of Obstetrics and Gynecology, 700398 Iasi, Romania.
- Department of Mother and Child, "Cuza Vodă" University Hospital of Obstetrics and Gynecology, 700036 Iasi, Romania.
ORCID-Profile: Tudor Butureanu, Raluca Anca Balan, Ioana Pavaleanu, Demetra Socolov, Razvan Socolov
Zitieren
APA
Butureanu, T., Apetrei, A. M., Balan, R. A., Haliciu, A. M., Pavaleanu, I., Socolov, D., & Socolov, R. (2026). Contraceptive-Induced Weight Gain—Myth and Reality Review. Life, 16(4), 553. https://doi.org/10.3390/life16040553
Vancouver
Butureanu T, Apetrei AM, Balan RA, Haliciu AM, Pavaleanu I, Socolov D, et al. Contraceptive-Induced Weight Gain—Myth and Reality Review. Life. 2026;16(4):553. doi:10.3390/life16040553
BibTeX
@article{Butureanu2026,
author = {Butureanu, Tudor and Apetrei, Ana-Maria and Balan, Raluca Anca and Haliciu, Ana-Maria and Pavaleanu, Ioana and Socolov, Demetra and Socolov, Razvan},
title = {Contraceptive-Induced Weight Gain—Myth and Reality Review},
journal = {Life},
year = {2026},
volume = {16},
number = {4},
pages = {553},
doi = {10.3390/life16040553}
}
EUVIMED